The COVID-19 Live Vaccine Tracker
Here is a compilation of the COVID-19 vaccine candidates that have achieved FDA Emergency Use Authorization, other approvals, and are in phases 1-3.
Coronavirus Science Is Not Binary
Why reducing pandemic research and response to yes-or-no outcomes is harming public health.
Webinar: Race for a COVID-19 Vaccine
MJH Life Sciences is presenting a webinar today on this important topic.
Connecting COVID-19 to Cancer Research
Dr. Adam Brufsky, an oncologist, compares viral and cancer immunity. Dr. Patrick Soon-Shiong connects the relation to COVID-19 vaccine research.
Setting Standards for a COVID-19 Vaccine
What should be anticipated in effectiveness and implication for the leading candidates.
Can We Fight Coronavirus Without a Vaccine? Explaining Monoclonal Antibody Research
What happens if we don't get a COVID-19 vaccine? Patrick Soon-Shiong, MD, describes another potential route for research efforts, which could also supplement vaccine development.
Adenovirus COVID-19 Vaccines: Challenges of Prior AD Immunity
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.
Can Moderna's COVID 19 Vaccine Generate Lasting Immunity?
Dr. Patrick Soon-Shiong, Chairman and CEO of ImmunityBio, explains why T-cell immunity could be an important metric when evaluating experimental COVID-19 vaccines.
2 Clarke Drive Cranbury, NJ 08512